| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04743661 | 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma | Recurrent Medulloblastoma | Active, Not Recruiting |
| NCT07424183 | T4/T3 Therapy in Hypothyroidism | Hypothyroidism Primary | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07346157 | Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal… | Medulloblastoma | Not Yet Recruiting |
| Not specified | |||
| NCT06647602 | Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy | Differentiated Thyroid Cancer | Not Yet Recruiting |
| NCT07568574 | Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes | Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Enrolling by Invitation |